| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (698kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-365375
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.36537
Zusammenfassung
Background Metformin is a commonly used oral antidiabetic agent that has been associated with decreased cancer risk. However, data regarding the association between metformin use and the risk of meningioma are unavailable. Methods We conducted a matched case-control analysis using data from the U. K.-based Clinical Practice Research Datalink (CPRD) to analyse diabetes status, duration of ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags